MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway

R-S Wu; E-H Qiu; J-J Zhu; J-R Wang; H-L Lin

doi:10.26355/eurrev_202008_22580

MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway

Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8240. doi: 10.26355/eurrev_202008_22580.

Authors

R-S Wu¹, E-H Qiu, J-J Zhu, J-R Wang, H-L Lin

Affiliation

¹ Department of Otolaryngology, the 2nd Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.

PMID: 32894520
DOI: 10.26355/eurrev_202008_22580

Abstract

The article "MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway, by R.-S. Wu, E.-H. Qiu, J.-J. Zhu, J.-R. Wang, H.-L. Lin, published in Eur Rev Med Pharmacol Sci 2018; 22(1): 150-157-DOI: 10.26355/eurrev_201801_14112-PMID: 29364482" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14112.

Publication types

Retraction of Publication